HCA Healthcare, Inc.
HCA
$531.47
$29.425.86%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.51B | 19.16B | 18.61B | 18.32B | 18.29B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.51B | 19.16B | 18.61B | 18.32B | 18.29B |
| Cost of Revenue | 11.34B | 11.15B | 10.98B | 10.76B | 10.71B |
| Gross Profit | 8.18B | 8.02B | 7.62B | 7.56B | 7.58B |
| SG&A Expenses | 1.03B | -- | -- | -- | 1.05B |
| Depreciation & Amortization | 911.00M | 889.00M | 863.00M | 860.00M | 856.00M |
| Other Operating Expenses | 3.06B | 4.16B | 3.79B | 3.85B | 2.82B |
| Total Operating Expenses | 16.34B | 16.20B | 15.64B | 15.47B | 15.44B |
| Operating Income | 3.18B | 2.97B | 2.97B | 2.86B | 2.85B |
| Income Before Tax | 2.67B | 2.42B | 2.42B | 2.33B | 2.13B |
| Income Tax Expenses | 509.00M | 515.00M | 524.00M | 502.00M | 447.00M |
| Earnings from Continuing Operations | 2.16B | 1.90B | 1.89B | 1.83B | 1.69B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -285.00M | -260.00M | -238.00M | -215.00M | -248.00M |
| Net Income | 1.88B | 1.64B | 1.65B | 1.61B | 1.44B |
| EBIT | 3.18B | 2.97B | 2.97B | 2.86B | 2.85B |
| EBITDA | 4.09B | 3.85B | 3.83B | 3.72B | 3.70B |
| EPS Basic | 8.14 | 7.05 | 6.91 | 6.52 | 5.63 |
| Normalized Basic EPS | 5.89 | 5.38 | 5.32 | 5.02 | 4.73 |
| EPS Diluted | 8.14 | 6.96 | 6.83 | 6.45 | 5.63 |
| Normalized Diluted EPS | 5.89 | 5.30 | 5.26 | 4.97 | 4.73 |
| Average Basic Shares Outstanding | 230.71M | 232.89M | 239.17M | 246.94M | 255.31M |
| Average Diluted Shares Outstanding | 230.71M | 236.18M | 241.91M | 249.44M | 255.31M |
| Dividend Per Share | 0.72 | 0.72 | 0.72 | 0.72 | 0.66 |
| Payout Ratio | 8.63% | 10.10% | 10.34% | 11.18% | 11.47% |